Navigation Links
Researchers find new, noninvasive way to identify lymph node metastasis
Date:1/12/2012

TAMPA, Fla. (Jan. 12, 2012) Using two cell surface markers found to be highly expressed in breast cancer lymph node metastases, researchers at Moffitt Cancer Center, working with colleagues at other institutions, have developed targeted, fluorescent molecular imaging probes that can non-invasively detect breast cancer lymph node metastases. The new procedure could spare breast cancer patients invasive and unreliable sentinel lymph node (SLN) biopsies and surgery-associated negative side effects.

Their study was published in a recent issue of Clinical Cancer Research (18:1), a publication of the American Association for Cancer Research.

"The majority of breast cancer patients, up to 74 percent, who undergo SLN biopsy are found to be negative for axillary nodal, or ALN, metastases," said corresponding author David L. Morse, Ph.D., an associate member at Moffitt whose research areas include experimental therapeutics and diagnostic imaging. "Determining the presence or absence of ALN metastasis is critical to breast cancer staging and prognosis. Because of the unreliability of the SLN biopsy and its potential for adverse effects, a noninvasive, more accurate method to assess lymph node involvement is needed."

The authors note that the postoperative complications to the SLN biopsy can include lymphedema, seroma formation, sensory nerve injury and limitations in patient range of motion. In addition, biopsies fail to identify disease in axillary lymph nodes in five to 10 percent of patients.

In developing targeted molecular probes to identify breast cancer in axillary lymph nodes, the research team from Moffitt, the University of Arizona and University of Florida used two surface cell markers CAIX and CAXII. CAIX is a cell surface marker known to be "highly and broadly expressed in breast cancer lymph node metastases" and absent in normal tissues.

CAIX and CAXII are both integral plasma membrane proteins with large extracellular components that are accessible for binding of targeted imaging probes, explained Morse. In addition, several studies have shown that CAIX expression is associated with negative prognosis and resistance to chemo and radiation therapy for breast cancer. CAXII is a protein expressed in over 75 percent of axillary lymph node metastases.

The researchers subsequently developed their targeting agents by using monoclonal antibodies specific for binding CAIX and CAXII, both of which are known to promote tumor growth.

According to the researchers, a number of noninvasive optical imaging procedures for SLN evaluation have been investigated, but the approaches have lacked the ability to target tumor metastasis biomarkers.

"These methods provide only anatomic maps and do not detect tumor cells present in lymph nodes," explained Morse. "Using mouse models of breast cancer metastasis and a novel, monoclonal anti-body-based molecular imaging agents, we developed a targeted, noninvasive method to detect ALN metastasis using fluorescence imaging."

In addition to the imaging study with mice, the researchers also reported that the combination of CAIX and CAXII covered 100 percent of patient-donated samples used in their tissue microarray (TMA) study.

"The imaging probes detected tumor cells in ALNs with high sensitivity," explained Morse. "Either CAIX or CAXII were expressed in 100 percent of the breast cancer lymph node metasatsis samples we surveyed in this study. These imaging probes have potential for providing a noninvasive way to stage breast cancer in the clinic without unneeded and costly surgery."


'/>"/>

Contact: Ferdie De Vega
Ferdinand.DeVega@moffitt.org
813-745-7858
H. Lee Moffitt Cancer Center & Research Institute
Source:Eurekalert

Related medicine news :

1. Hopkins researchers find Google Flu Trends a powerful early warning system for emergency departments
2. Researchers Look at Genomes of Nonsmokers With Lung Cancer
3. Researchers discover new culprit in atherosclerosis
4. TGen researchers map potential genetic origins, pathways of lung cancer in nonsmokers
5. Researchers Identify Liver Cancer Risk Factors
6. Researchers find malignancy-risk gene signature for early-stage non-small cell lung cancer
7. Potential Herpes Vaccine Disappoints Researchers
8. Fibroblasts contribute to melanoma tumor growth, say Moffitt Cancer Center researchers
9. Researchers discover protein that may represent new target for treating type 1 diabetes
10. BUSM researchers identify novel compound to halt virus replication
11. BINGO! game helps researchers study perception deficits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... , ... May 23, 2016 , ... NYDNRehab, a New ... program for athletes. This is the first time this type of technology, which was ... made available to the public in New York. , With over 10 million ...
(Date:5/23/2016)... Diego, CA (PRWEB) , ... May 23, 2016 , ... ... various regulatory subjects will host medical device summit on September 15 and 16, ... world’s leading experts and former FDA office bearers will be one of the largest ...
(Date:5/23/2016)... (PRWEB) , ... May 23, ... ... and security executive networking and relationship-marketing firm, announced today that nominations will ... Information Security Executive® (ISE®) Northeast Awards. , Awards include the Information Security ...
(Date:5/23/2016)... ... May 23, 2016 , ... ... education worldwide for people who are blind or visually impaired, announces the election ... retiring President Charles E. Young. Hadley’s Board of Trustees retained Morris & Berger, ...
(Date:5/23/2016)... ... 2016 , ... Octo Consulting Group, a leading provider of innovative information technology ... they have recently won two awards from AFCEA International. Octo was selected as ... Additionally, Octo VP of Civilian Affairs, Naina Leo, was named a winner of the ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... The global  reprocessed medical devices ... 2022, according to a new study by Grand View ... with the lack of centralized support for waste disposal ... demand for reprocessed medical devices market. Additionally, the long-term ... of the original device is the high impact rendering ...
(Date:5/20/2016)... 2016 ReportsnReports.com adds Global ... Devices of its online business intelligence library. This ... current state of the Titrator industry. The report ... definitions, classifications, Specifications, applications and industry chain structure. ... Raw Material Suppliers, Equipment Suppliers, Manufacturing Cost Structure, ...
(Date:5/20/2016)... India , May 20, 2016 ... growth driver is the increasing demand for affordable healthcare solutions ... been steadily on the rise. In countries like the US, ... decade. In the US, the consumer price index inflation rate ... healthcare inflation rate moved up to 3.62% during the same ...
Breaking Medicine Technology: